Fibro Daily

FDA Votes Thumb Down on Zohydro ER

Fibro Daily December 7, 2012

Opioid Zohydro ER received a thumbs down today from the Federal Food and Drug Administration (FDA), who worry that the potential abuse of the drug far outweighs any benefits.

The drug is designed to provide relief for moderate to severe chronic pain.

Furthermore, fear about the drug getting into the wrong hands runs high.

Read more:

FDA Panel Gives Thumbs Down to Opioid



Powered by Facebook Comments

Tagged with:

Comments are closed.

Login to your account

Can't remember your Password ?

Register for this site!